avrg: GSE58827: Dynamics of the Mouse Liver
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Gata1 | mm10_v2_chrX_-_7964166_7964191 | 0.89 | 2.4e-13 | Click! |
Gata2 | mm10_v2_chr6_+_88198656_88198675 | 0.83 | 3.6e-10 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr17_-_26199008 Show fit | 69.41 |
ENSMUST00000142410.1
ENSMUST00000120333.1 ENSMUST00000039113.7 |
protein disulfide isomerase associated 2 |
|
chr4_-_46404224 Show fit | 64.49 |
ENSMUST00000107764.2
|
hemogen |
|
chr6_+_41458923 Show fit | 59.97 |
ENSMUST00000031910.7
|
protease, serine, 1 (trypsin 1) |
|
chr2_+_84980458 Show fit | 57.88 |
ENSMUST00000028467.5
|
proteoglycan 2, bone marrow |
|
chr2_-_121036750 Show fit | 55.99 |
ENSMUST00000023987.5
|
erythrocyte protein band 4.2 |
|
chr11_+_32276400 Show fit | 54.81 |
ENSMUST00000020531.2
|
hemoglobin X, alpha-like embryonic chain in Hba complex |
|
chr6_+_30639218 Show fit | 54.60 |
ENSMUST00000031806.9
|
carboxypeptidase A1, pancreatic |
|
chr6_-_41704339 Show fit | 52.84 |
ENSMUST00000031899.8
|
Kell blood group |
|
chr6_+_41392356 Show fit | 52.67 |
ENSMUST00000049079.7
|
predicted gene 5771 |
|
chr8_+_84701430 Show fit | 51.74 |
ENSMUST00000037165.4
|
lymphoblastomic leukemia 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 261.7 | GO:0006508 | proteolysis(GO:0006508) |
12.3 | 98.3 | GO:0015671 | oxygen transport(GO:0015671) |
13.2 | 79.4 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
7.4 | 66.9 | GO:0002432 | granuloma formation(GO:0002432) |
1.6 | 61.1 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
19.3 | 57.9 | GO:0002215 | defense response to nematode(GO:0002215) |
8.8 | 52.8 | GO:0031133 | regulation of axon diameter(GO:0031133) |
7.4 | 51.7 | GO:0001955 | blood vessel maturation(GO:0001955) |
2.1 | 49.0 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
8.0 | 47.8 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 283.1 | GO:0005615 | extracellular space(GO:0005615) |
12.3 | 98.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.2 | 81.2 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 75.1 | GO:0070062 | extracellular exosome(GO:0070062) |
0.4 | 74.4 | GO:0032993 | protein-DNA complex(GO:0032993) |
6.6 | 72.9 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.2 | 56.3 | GO:0042383 | sarcolemma(GO:0042383) |
0.1 | 49.6 | GO:0015629 | actin cytoskeleton(GO:0015629) |
1.4 | 44.4 | GO:0097228 | sperm principal piece(GO:0097228) |
0.0 | 40.3 | GO:0005730 | nucleolus(GO:0005730) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 167.3 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
4.1 | 132.7 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
12.3 | 98.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
11.3 | 79.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
6.3 | 69.4 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.5 | 68.5 | GO:0005178 | integrin binding(GO:0005178) |
0.3 | 66.6 | GO:0017137 | Rab GTPase binding(GO:0017137) |
1.0 | 47.8 | GO:0030552 | cAMP binding(GO:0030552) |
0.4 | 45.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
2.8 | 45.1 | GO:0008301 | DNA binding, bending(GO:0008301) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 69.6 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.8 | 66.1 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
1.3 | 57.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 54.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
1.2 | 40.0 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.4 | 28.0 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 23.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.9 | 22.3 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.2 | 20.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.5 | 19.1 | PID BCR 5PATHWAY | BCR signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 60.4 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
1.5 | 44.0 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
1.3 | 41.6 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.9 | 41.1 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.8 | 39.9 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.7 | 29.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.6 | 28.6 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
1.4 | 28.0 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.9 | 21.7 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.9 | 19.7 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |